MedPath

Feasibility study of UFT after surgery with platinum based adjuvant chemotherapy in completely resected pathological stage II/IIIA non-small cell lung cancer

Phase 2
Conditions
completely resected pathological stage II/IIIA non-small cell lung cancer
Registration Number
JPRN-UMIN000003223
Lead Sponsor
Department of Surgery, Division of Chest Surgery, St.Marianna University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1) not recovered from surgical complications 2) active infection such as bacterial infection 3) patients with interstitial pneumonaitis or pulmonary fibrosis, as determined by chest CT 4) patients with myocardial infraction within 6 months 5) patients with uncontroled complications 6) grade 2 or greater peripheral neuropathy 7) Active another neoplasm 8) pregnant or lactating women 9) concomitant therapy with other fluoropyrimmidine 10) pneumonectomy 11) Patient who is judged to be inappropriate as subject to this study by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility, relative performance
Secondary Outcome Measures
NameTimeMethod
relapse-free survival , Overall survival , safety
© Copyright 2025. All Rights Reserved by MedPath